Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

KZIA — KAZIA THERAPEUTICS LTD SEC Filings | FilingIndex

KZIANasdaq

KAZIA THERAPEUTICS LTD

Pharmaceutical Preparations · C3 · CIK 1075880

Kazia Therapeutics develops oncology drugs, focusing on brain cancer treatments like its lead candidate, Paxalisib

+ Watch View on EDGAR ↗

$163M

Market cap

$14.08

Last close

-2.6%

1D

-4.2%

5D

128K

Volume

Price · last 40 sessions+9.7%

May 4L $10.95 · H $14.69Jun 30

668

Total filings

Jun 2, 2026

Last filing

06/30

Fiscal year end

All 6-K · 634 20-F · 20 424B5 · 6 SC 13G · 6 10-Q · 1 SC 13D · 1

SC 13GSC 13GNov 6, 2024 SC 13GSCHEDULE 13GJul 2, 2024 SC 13GSC 13GFeb 14, 2024 SC 13GSC 13GFeb 12, 2024 SC 13GSC 13GJul 2, 2015 SC 13G

Similar companies

Comparable business profile · signals at a glance

CELCCelcuity Inc.$4.3B+2.0%VSTMVerastem, Inc.$360.3M0.0%NUVBNuvation Bio Inc.$1.7B+1.3%NRIXNurix Therapeutics, Inc.🔥$1.8B+1.7%RIGLRIGEL PHARMACEUTICALS INC

FORM SC 13G

Apr 9, 2012

$607.8M

+0.2%

PRAXPraxis Precision Medicines, Inc.$7.4B-4.5%